Medical/Pharmaceuticals

JW Therapeutics Announces Updated 1-year Follow-up Result of Relmacabtagene Autoleucel Injection At the 24th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)

SHANGHAI, Sept. 26, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced updated 1-year follow-up result of relmacabtagene autoleucel injection (relma-cel) for t...

2021-09-26 20:00 798

Qiming's Portfolio Company Broncus Lists on Main Board of HKEx

SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Broncus (SEHK:2216),  a pioneer inChina's interventional pulmonology navigation device market, today listed on the main board of Hong Kong Stock Exchange. The issue price isHK$ 18.7/share, representing a market ca...

2021-09-24 14:10 9709

New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA

HONG KONG, Sept. 24, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the National Medical Products Administration (the NMPA) ofChina has officially accepted the new drug application for the world's first-in-class Cadonilimab (PD-1/CTLA-4 bi-specific antibody, research and d...

2021-09-24 14:09 472

Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206

SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inAsia, an...

2021-09-24 13:56 1258

Broncus Lists on Main Board of HKEx

HONG KONG, Sept. 24, 2021 /PRNewswire/ -- On September 24, Broncus (02216.HK), a pioneer in the field of interventional pulmonology inChina, was successfully listed on the main board of the Hong Kong Stock Exchange. Broncus, founded in 2012, is a medical device company focused on the development...

2021-09-24 11:52 2645

Johnson & Johnson Innovation Announces Awardees of the Digital Technologies of Tomorrow QuickFire Challenge

Awardees HelpWear and Us2.ai recognized for their novel ideas to harness the Internet of Things (IoT) and Artificial Intelligence (AI) with the aim to transform Atrial fibrillation (AFIB) patient care. SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Johnson & Johnson Innovation LLC together with Johnso...

2021-09-24 09:02 1265

Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases

- Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu™ vaccine candidate induced significantly enhanced cell-mediated immune responses - NanoFlu was well-tolerated with a comparable safety profile...

2021-09-24 08:47 2455

Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis

SAN FRANCISCO and SUZHOU, China, Sept. 24, 2021 /PRNewswire/ -- Innovent Biologics, Group. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major d...

2021-09-24 08:00 1341

/C O R R E C T I O N -- pHOXBIO/

In the news release, pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2, issued Sept. 22, 2021 by pHOXBIO over PR Newswire, we are advised by the company that the hyperlinks have been revised. The complete, corrected releas...

2021-09-24 02:42 1025

Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine

* Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedic...

2021-09-23 21:59 3925

Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021

HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards. The nomination is based on Nanoform being a listed com...

2021-09-23 20:15 865

BIORCHESTRA appoints pharma veteran and Moderna and Akcea (Ionis) CMO "Dr. Louis St. L. O'Dea" as CMO of BIORCHESTRA

BOSTON, Sept. 23, 2021 /PRNewswire/ -- BIORCHESTRA is a bio-tech company focused on the identification of novel targets in neurodegenerative diseases using RNA-based therapeutics. To access these novel targets, BIOCHESRTRA has also developed a proprietary nanoparticle formulation to deliver RNA-b...

2021-09-23 20:00 717

Insilico Medicine Appoints Nirav Jhaveri as Chief Financial Officer

NEW YORK and HONG KONG, Sept. 23, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end artificial intelligence (AI)-powered drug discovery company, today announced the appointment ofNirav Jhaveri as Chief Financial Officer (CFO) to oversee capital markets, investor relations, financial operation...

2021-09-23 20:00 772

"Human Brains: Conversations", an online project dedicated to brains studies and presented by Fondazione Prada

MILAN, Sept. 23, 2021 /PRNewswire/ -- Fondazione Prada presents the online project "Human Brains: Conversations," the second phase of the multidisciplinary program "Human Brains" dedicated to brain studies. "Conversations" will take place fromSeptember 2021 to April 2022 and will be availabl...

2021-09-23 18:00 785

Hainan Boao Lecheng International Medical Tourism Pilot Zone holds event to attract Japanese investment

The event is co-organized by Winhealth Pharma BOAO, China, Sept. 23, 2021 /PRNewswire/ -- The Hainan Boao Lecheng International Medical Tourism Pilot Zone ("Lecheng Pilot Zone")'s virtual promotional event to explain the favorable investment policies put in place for Japanese businesses, hosted ...

2021-09-23 16:15 812

AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials

SINGAPORE, Sept. 23, 2021 /PRNewswire/ -- Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates the efficient completion of oncology feasibility studies supported by near real-ti...

2021-09-23 16:07 1031

Lion TCR Announces FDA IND Clearance for its LioCyx-M004 for Hepatocellular Carcinoma

SINGAPORE and Guangzhou, China and LOS ANGELES, Sept. 23, 2021 /PRNewswire/ -- Lion TCR Pte Ltd, a clinical-stage biotech company specialized in T Cell Receptor (TCR) T cell therapy today announced that it has received clearance from U.S. Food and Drug Administration (FDA) for its Investigational...

2021-09-23 15:23 904

BioVaxys Prepares for Groundbreaking Study on reduced ACE2 binding capabilities of Hapten-modified SARS-CoV-2 proteins

- Potential for superior tolerability to mRNA and Adenovirus Vector vaccines - Production Agreement signed with Millipore-Sigma for SARS-CoV-2 Vaccine Supply VANCOUVER, BC, Sept. 23, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), a...

2021-09-23 15:00 3181

Zymo Research Receives CE IVD Mark for its EZ DNA Methylation-Lightning Kit

Proven bisulfite technology ideal for clinical applications IRVINE, Calif., Sept. 23, 2021 /PRNewswire/ -- Today Zymo Research announced itsEZ DNA Methylation-Lightning Kit™ has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemi...

2021-09-23 14:48 757

Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Therapy for Esophageal Squamous Cell Carcinoma (ESCC)

SAN FRANCISCO and SUZHOU, China, Sept. 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2021-09-23 08:00 1335
12345 ... 281

Week's Top Stories